PrimeVax Immuno-Oncology
Biotechnology Research
South San Francisco, California, United States
7 employees
- Employees
- 7
PrimeVax Immuno-Oncology Overview
- Headquarters
- South San Francisco, California, United States
- Website
- primevax.com
- Industry
- Biotechnology Research
- Employees
- 7
- Founded
- 2015
- Company Email
- Available in AeroLeads
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
Keywords
About PrimeVax Immuno-Oncology
PrimeVax Immuno-Oncology, Inc. is developing the only one-time, one-week cancer treatment. We use a combination of the dengue fever virus and autologous dendritic cells to induce a strong immune response along with personalized tumor targeting.
PrimeVax Immuno-Oncology Contact Details
- People in AeroLeads
- 4
PrimeVax Immuno-Oncology Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Jim Jordan | Founder & CEO, White Cross Worldwide® |
View
|
|
| Bob Battista | Board Member, Executive, Founder |
View
|
|
| Tony Chen | Founder / President @ Primevax |
View
|
|
| Warren Williams | Founder & Chief Technology Officer @ |
View
|
Employees by Management Level
Executive
4 profiles
Compare Similar Companies to PrimeVax Immuno-Oncology
Orion Biotechnology
Pharmaceutical Manufacturing
Ignite Tournaments
Mobile Gaming Apps
KeyOps
Market Research
RxFood Corporation
Hospitals And Health Care
Careteam Technologies
Hospitals And Health Care
Rehabtronics
Medical Equipment Manufacturing
Difinity Solutions
Medical Equipment Manufacturing
Neurovine
Wellness And Fitness Services
Akrivia Biomedics Limited
Health And Human Services
CleanSlate UV
Medical Device